-
Pankaj Patel owned Cadila ups its India game with AZ’s brands
UK drug maker AstraZeneca has divested its brands in anti-infective and women’s health portfolio to Zydus Healthcare, a subsidiary of Cadila Healthcare as the company narrows down its therapy areas.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
MobileODT’s Goal: Making Cervical Cancer Screening Available to Every Woman, Everywhere – at a Profit
Cervical cancer is a leading cause of death worldwide, but most of those deaths could be prevented through early detection. MobileODT has developed a low-cost colposcope that uses smartphones to replace more complex and expensive cervical screening systems. Here, CEO and cofounder Ariel Beery talks his company's plans to reach billions of people in both developed and developing countries.
- Categories
- Health Care
-
Iron Supplement Bars Reduced Anemia in Women in India
An iron supplement bar given to anemic women in and around Mumbai, India, led to increased hemoglobin and hematocrit levels, reducing anemia with no reported side effects, according to a study by Duke University researchers and collaborators in India.
- Categories
- Health Care
- Region
- South Asia
- Tags
- nutrition
-
The Billionaire Backing a Tech Solution to Water Access
Ajay Piramal is leveraging technology to transform life for India’s poorest, by bringing clean water through ATM-style dispensers in remote villages.
- Categories
- Health Care
- Region
- South Asia
-
Social Business Roundup: An SDG Lovefest at Davos, a New Rival for M-Pesa and a Really Big Direct Investment Fund
Has the World Economic Forum in Davos lost its relevance? Not to the folks gathered there this week who were knee-deep in talk about sustainable investing and social enterprise. Those discussions are only the start of a jam-packed Roundup this week. There's also a new mobile platform by MasterCard that could rival M-Pesa in Kenya, plans for a $2 billion direct investment fund, and plenty more ...
- Categories
- Agriculture, Health Care
-
Drugmakers in Davos Shift Focus to Chronic Diseases of Poor
Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Donors and Drug Makers Offer $500 Million to Control Global Epidemics
Stung by the lack of vaccines to fight the West African Ebola epidemic, a group of prominent donors announced Wednesday that they had raised almost $500 million for a new partnership to stop epidemics before they spiral out of control.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Tragedy Would Unfold If Trump Cancels Bush’s AIDS Program
In 2003, in a move that has been described as his greatest legacy, George W. Bush created a program called PEPFAR—the President's Emergency Plan for AIDS Relief. At the time, more than 20 million people in sub-Saharan Africa were living with AIDS, but only 50,000 had access to antiretroviral drugs that manage the disease and prevent its spread. Now, thanks to PEPFAR, 11.5 million people are on those drugs. For good reason, it has been variously described as a “globally transformative lifeline,” “one of the best government programs in American history,” and something “for all Americans to be proud of.”
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.